FORE Biotherapeutics Archives

FORE Biotherapeutics has raised $67,400,000.00 in new Series D funding

August 19, 2026 Craig Etkin

According to filings with the U.S. Securities and Exchange Commission, FORE Biotherapeutics has raised $67,400,000.00 in new Series D funding. The federal securities law requires the notice to be filed by companies that have sold…

FORE Biotherapeutics Raises $38 Million in Series D-2 Financing for the Continued Advancement of Plixorafenib

May 28, 2025 Craig Etkin

Financing extends Company’s cash runway beyond important clinical milestones anticipated beginning in 2H25, supporting the ongoing execution of the FORTE Master Protocol evaluating plixorafenib as a monotherapy in three distinct patient populations PHILADELPHIA–(BUSINESS WIRE)–FORE Biotherapeutics,…

intelligence360

The Intelligent News Source

Tag: FORE Biotherapeutics

FORE Biotherapeutics has raised $67,400,000.00 in new Series D funding

August 19, 2026 Craig Etkin

FORE Biotherapeutics Raises $38 Million in Series D-2 Financing for the Continued Advancement of Plixorafenib

May 28, 2025 Craig Etkin